TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Living Cell Technologies ( (AU:1AI) ) is now available.
Algorae Pharmaceuticals has announced its upcoming Annual General Meeting (AGM) scheduled for October 2, 2025. The meeting will address various agenda items, and shareholders will receive detailed information on participation. This announcement is part of Algorae’s ongoing efforts to engage with stakeholders and maintain transparency in its operations.
More about Living Cell Technologies
Algorae Pharmaceuticals is an AI-enabled pharmaceutical development company focused on discovering and developing synergistic drug combinations for unmet medical needs. Utilizing its proprietary AI platform, AlgoraeOS, the company collaborates with research institutions and pharmaceutical partners to translate AI-predicted therapies into clinical applications. Algorae is publicly traded on the Australian Stock Exchange.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.12M
See more data about 1AI stock on TipRanks’ Stock Analysis page.